UnitedHealth Group stock gains on fresh analyst buy ratings and earnings guidance

Published on 09/16/2026 at 14:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UnitedHealth Group stock trades around USD 376 in mid-September 2026 as analysts reiterate Buy ratings with upside of more than 20 percent as of September 14, 2026. The company targets adjusted EPS of 19.50 to 20.00 dollars for fiscal year 2026, underlining its growth ambitions.

Fotorealistisches Krankenhaus-Außengebäude bei Sonnenuntergang mit Glasfassade und Fußgängern — UnitedHealth Group US91324P1021 zeigt modernes Krankenhaus im Sonnenuntergang mit Glasfassade und Besuchern, Illustration mit AI erstellt.

UnitedHealth Group stock (ISIN US91324P1021) is trading around USD 376 in mid-September 2026, with analysts highlighting more than 20 percent upside potential based on recent price targets as of September 14, 2026. As TipRanks reported on September 16, 2026, UnitedHealth Group carries a Strong Buy consensus with an average 12-month price target of USD 481.58, implying approximately 28.1 percent upside from current levels.

Analysts reiterate Buy calls with double-digit upside

According to TipRanks on September 16, 2026, five-star analyst A.J. Rice of UBS reiterated his Buy rating on UnitedHealth Group on September 14, 2026 and maintained a price target of USD 490 per share, citing management’s confidence in sustaining mid-teens earnings per share growth.

The same TipRanks overview notes that UnitedHealth Group has an average 12-month price target of USD 481.58 from Wall Street analysts, which represents roughly 28.1 percent upside compared with the current share price level around USD 376 as referenced in mid-September 2026. This quantified gap between the prevailing market price and consensus targets is a key focus for investors assessing the risk-reward profile of UnitedHealth Group stock.

In addition to UBS, Evercore ISI has also reiterated a positive stance. As The Globe and Mail reported on September 15, 2026, Evercore ISI analyst Elizabeth Anderson maintained a Buy rating on UnitedHealth Group and set a price target of USD 480.00 per share, close to the broader consensus level and reinforcing expectations for continued gains.

Guidance underpins earnings growth expectations

Beyond ratings, the company’s own guidance supports the growth narrative. According to MarketBeat on September 16, 2026, UnitedHealth Group has set its fiscal year 2026 earnings per share guidance at USD 19.50 to USD 20.00.

The same MarketBeat coverage highlights that sell-side analysts currently expect UnitedHealth Group to post about USD 19.82 EPS for the full year, which sits within the company’s guidance range and implies mid-teens growth versus historical levels. In this context, UnitedHealth Group’s forward price-to-earnings multiple around 19.6 times, as referenced by Yahoo Finance on September 15, 2026, reflects investors’ willingness to pay a premium for steady earnings expansion.

UnitedHealth Group’s focus on technology and artificial intelligence in health care also plays into the growth story. As Yahoo Finance wrote on September 15, 2026, UnitedHealth Group closed at USD 383.55 per share on September 14, 2026 and has gained 10.86 percent over the past 52 weeks, while declining 4.38 percent over the past month, illustrating the interplay between short-term volatility and longer-term performance as the company invests in AI-driven insurance and health services.

Dividend and upcoming earnings date add visibility

Income-focused investors are also watching UnitedHealth Group’s dividend stream. According to Business Wire on September 15, 2026, the UnitedHealth Group board of directors authorized payment of a cash dividend of USD 2.32 per share, to be paid on September 22, 2026 to shareholders of record as of the close of business on September 14, 2026.

The same Business Wire notice indicates that the company tied this dividend declaration to its next earnings release date, giving investors a near-term catalyst as they assess whether earnings momentum and cash generation continue to support both dividend growth and share repurchases. With a trailing dividend yield of about 2.46 percent and a market capitalization near USD 338.48 billion as highlighted by MarketBeat on September 16, 2026, UnitedHealth Group remains one of the largest and most liquid healthcare stocks in the S&P 500.

At the same time, research commentary has flagged potential risks. As Simply Wall St noted on September 15, 2026, UnitedHealth Group recently updated investors on improving medical cost trends, a higher 2026 adjusted EPS outlook, and progress in repairing Optum Health margins. Lower-than-expected medical costs support profitability, but regulatory scrutiny and competitive pressures in managed care remain key risk factors for the stock.

Stock trades below 52-week high but above recent lows

From a market perspective, UnitedHealth Group stock is trading below its recent highs but comfortably above the 52-week low. According to MarketBeat on September 16, 2026, UnitedHealth Group shares trade in a 52-week range between USD 255.96 and USD 461.62, with a current price around USD 376.48 and a market capitalization of roughly USD 338.48 billion as of mid-September 2026.

Data from CNN Markets show that UnitedHealth Group last closed at USD 383.55 per share on September 14, 2026 on the New York Stock Exchange, up USD 4.46 or 1.18 percent from the prior session, before slipping modestly in pre-market trading on September 15, 2026. This puts the stock about 16.9 percent below the 52-week high of USD 461.62 and roughly 47 percent above the 52-week low of USD 255.96, underscoring the substantial recovery from prior weakness but leaving room for further gains if earnings and guidance are delivered as expected.

Short-term volatility has also been influenced by broader market moves. As China Daily reported on September 16, 2026, US stocks recently closed lower amid concerns over oil supply, and Dow Jones constituents such as Microsoft and UnitedHealth Group showed weakness in that session. For investors in UnitedHealth Group stock, this illustrates how macro factors can temporarily outweigh company-specific fundamentals.

UnitedHealth Group stock price and investor takeaway

UnitedHealth Group stock last closed at USD 383.55 on the New York Stock Exchange on September 14, 2026, with intraday and pre-market data around USD 376 to USD 382 in the following sessions, in US dollars. With consensus earnings expectations around USD 19.82 per share for the current year and company guidance in the range of USD 19.50 to USD 20.00 EPS for fiscal year 2026, the valuation and analyst targets suggest further upside potential if UnitedHealth Group can maintain mid-teens earnings growth while managing medical costs and regulatory risks.